De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

TCI Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yung-Hsiang Lin

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	7.4yrs
Eigendom CEO	1.2%
Management gemiddelde ambtstermijn	3.4yrs
Gemiddelde ambtstermijn bestuur	5.1yrs

Recente managementupdates

Recent updates

CEO

Yung-Hsiang Lin

7.4yrs

Tenure

Mr. Yung-Hsiang Lin serves as the Chairman, CEO & General Manager of TCI Co., Ltd and has been its Director since May 2017. He holds Bachelor Degree in Botany from National Chung Hsing University. He was a...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Yung-Hsiang Lin	Chairman	no data	geen gegevens	1.21% NT$ 196.4m
Chien Tien Huang	Assistant Manager	no data	geen gegevens	geen gegevens
Chen-Chia Huang	Head of Corporate Governance	5yrs	geen gegevens	geen gegevens
Wei-Chiang Chi	Head of Audit Department	10yrs	geen gegevens	geen gegevens
Tung- Wei Li	US Regional Managing Director	2.6yrs	geen gegevens	geen gegevens
Ching-Ting Chen	Head of Research and Design Center and Institutional Director	4.7yrs	geen gegevens	0.059% NT$ 9.6m
Chiao-Ling Li	Head of Talent Development Center	2.5yrs	geen gegevens	geen gegevens
Hao-Chun Wang	Head of Strategic Intelligence Center	2.5yrs	geen gegevens	geen gegevens
Chiu- Yueh Li	Head of Precise iManufacturing	2.5yrs	geen gegevens	geen gegevens
Juen-Ying Chiou	Head of Stock Service Team	4.3yrs	geen gegevens	geen gegevens

3.4yrs

Gemiddelde duur

Ervaren management: Het managementteam van 8436 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yung-Hsiang Lin	Chairman	7.4yrs	geen gegevens	1.21% NT$ 196.4m
Ching-Ting Chen	Head of Research and Design Center and Institutional Director	less than a year	geen gegevens	0.059% NT$ 9.6m
Sung-Yuan Liao	Independent Director	7.4yrs	geen gegevens	geen gegevens
Chen-Yi Kao	Independent Director	7.4yrs	geen gegevens	geen gegevens
Pi-Shu Li	Representative Director	5.1yrs	geen gegevens	0.0011% NT$ 181.3k
Shih-Ming Li	Independent Director	4.3yrs	geen gegevens	geen gegevens
Shu-Min He	Independent Director	4.3yrs	geen gegevens	0.00085% NT$ 137.6k

5.1yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 8436 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.1 jaar).

TCI Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

TCI Co., Ltd. Announces Executive Changes

TCI Co., Ltd. Appoints Members of the Risk Management Committee

Recent updates

TCI Co., Ltd. to Report Q2, 2024 Results on Jul 30, 2024

Dividend of NT$7.00 announced

New major risk - Revenue and earnings growth

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

Consensus EPS estimates increase by 16%

First quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% overvalued

TCI Co., Ltd. Board Approves Dividend Distribution for the Year Ended December 31, 2023

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Consensus revenue estimates fall by 12%

Full year 2023 earnings: EPS and revenues miss analyst expectations

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

TCI Co., Ltd. Unveils Weight Loss Formula at SupplySide West 2023

Upcoming dividend of NT$5.02 per share at 4.8% yield

TCI Co., Ltd. Announces Cash Dividend, Payable on August 22, 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

TCI Introduces Vecollal

TCI Introduces Vecollal

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

Consensus EPS estimates fall by 26%

TCI Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2022

Now 22% undervalued

Now 20% undervalued

Price target increased by 11% to NT$179

Consensus forecasts updated

Price target increased to NT$177

Investor sentiment improved over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

TCI Co., Ltd. Announces Executive Changes

Consensus EPS estimates fall by 31%

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of NT$8.92 per share

TCI Co., Ltd. Approves Cash Dividend, Payable on August 18, 2022

Price target decreased to NT$183

TCI Co., Ltd. Appoints Members of the Risk Management Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Price target decreased to NT$197

TCI Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to NT$197

Consensus EPS estimates fall by 13%

Price target decreased to NT$258

Price target decreased to NT$278

Price target decreased to NT$283

Third quarter 2021 earnings released: EPS NT$4.02 (vs NT$4.23 in 3Q 2020)

Upcoming dividend of NT$8.88 per share

Second quarter 2021 earnings released: EPS NT$4.19 (vs NT$4.50 in 2Q 2020)

Investor sentiment improved over the past week

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Head of Finance Department & CFO Chia- Chi Li has left the company

Price target increased to NT$249

Price target increased to NT$240

First quarter 2021 earnings released: EPS NT$3.25 (vs NT$3.13 in 1Q 2020)

Is TCI Co., Ltd. (GTSM:8436) A Smart Choice For Dividend Investors?

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Analysts lower EPS estimates to NT$15.17

TCI Co., Ltd. (GTSM:8436) made an offer to acquire 30% stake in Maxigen Biotech Inc. (TSEC:1783) for approximately TWD 600 million.

Price target lowered to NT$235

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Revenue and earnings miss expectations

New 90-day high: NT$221

Is TCI's (GTSM:8436) 160% Share Price Increase Well Justified?

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

New 90-day low: NT$197